Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001601830-24-000196
Filing Date
2024-11-06
Accepted
2024-11-06 16:18:48
Documents
76
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rxrx-20240930.htm   iXBRL 10-Q 1049912
2 EX-31.1 exhibit311-q0324.htm EX-31.1 7385
3 EX-31.2 exhibit312-q0324.htm EX-31.2 7372
4 EX-32.1 exhibit321-q0324.htm EX-32.1 3283
10 rxrx-20240930_g1.jpg GRAPHIC 696283
11 rxrx-20240930_g2.jpg GRAPHIC 993620
  Complete submission text file 0001601830-24-000196.txt   10634170

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rxrx-20240930.xsd EX-101.SCH 50931
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rxrx-20240930_cal.xml EX-101.CAL 93445
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rxrx-20240930_def.xml EX-101.DEF 247026
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rxrx-20240930_lab.xml EX-101.LAB 583730
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rxrx-20240930_pre.xml EX-101.PRE 409296
79 EXTRACTED XBRL INSTANCE DOCUMENT rxrx-20240930_htm.xml XML 913676
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Filer) CIK: 0001601830 (see all company filings)

EIN.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40323 | Film No.: 241431285
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)